<unk>  is a colony stimulating factor that is FDA approved for the treatment of severe neutropenia in patients with non‑myeloid malignancies receiving myelosuppressive anti‑cancer drugs associated with a clinically significant incidence of febrile neutropenia.   Common adverse reactions include bone pain.
Filgastrim
Creatinolfosfate
Hexetidine
Sucralfate
Ioxaglic acid
Nepafenac
Ornidazole
Azficel-T